Fabrication and In Vivo Evaluation of In Situ pH-Sensitive Hydrogel of Sonidegib–Invasomes via Intratumoral Delivery for Basal Cell Skin Cancer Management
Background/Objectives: Basal cell skin cancer (BCSC) develops when skin cells proliferate uncontrollably. Sonidegib (SDB) is a therapeutic option for the treatment of BCSC by inhibiting hedgehog signaling. The problems with SDB’s low solubility, poor bioavailability, resistance, poor targeting, and...
Saved in:
Main Authors: | Maha M. Ghalwash, Amr Gamal Fouad, Nada H. Mohammed, Marwa M. Nagib, Sherif Faysal Abdelfattah Khalil, Amany Belal, Samar F. Miski, Nisreen Khalid Aref Albezrah, Amani Elsayed, Ahmed H. E. Hassan, Eun Joo Roh, Shaimaa El-Housiny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/1/31 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing transdermal drug delivery: formulation and evaluation of simvastatin-loaded invasomes in carbopol gel for improved permeability and prolonged release
by: Deepak Kumar Dash, et al.
Published: (2025-01-01) -
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): a case report
by: Noura Abdul Rahman, et al.
Published: (2025-01-01) -
Efecto de la biofumigación con repollo sobre el control de Fusarium oxysporum en suelo
by: L.E. IRIARTE, et al.
Published: (2011-01-01) -
Mixed representations of choice direction and outcome by GABA/glutamate cotransmitting neurons in the entopeduncular nucleus
by: Julianna Locantore, et al.
Published: (2025-01-01) -
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
by: Dawn Odom, et al.
Published: (2017-01-01)